welcome
Working for the people to improve healthcare

CIBBIM-Nanomedicine Director

Dr. Simó Schwartz Jr


Nanomedicine and Advanced Therapies as translational sciences have the ultimate goal to provide cost effective novel therapies and diagnostics. As key enable technologies these new options will cause profound changes in healthcare, making feasible more personalized, predictive, preventive, and regenerative medicine.

PRECLINICAL SERVICES

This platform offers standard in vitro experimentation procedures for the functional validation of candidate genes and biomarkers, and for the efficacy and toxicological evaluation of new drugs, biomaterials and biomarkers.
Read more

At the moment, the platform offers standardin vivo experimentation procedures for the evaluation of new therapeutic targets, nanotherapies and biomarkers in the field of oncology and rare diseases.
Read more

Latest
news

News

Dr. Simó Schwartz Jr, appointed editor of the Precision Nanomedicine journal

Dr. Simó Schwartz Jr, appointed editor of the Precision Nanomedicine journal

In the coming days the Precision Nanomedicine journal will see the light, in its online version that is already being finalised. Dr. Simón Schwartz Jr, director of...

Read more
The team of Dr. Simó Schwartz Jr gets a polymeric nanomedicine which facilitates concurrent therapies of pharmacological and gene silencing

The team of Dr. Simó Schwartz Jr gets a polymeric nanomedicine which facilitates concurrent therapies of pharmacological and gene silencing

One of the main problems that nanomedicine must face is the improvement of drugs transport and release systems to the correct place of action. And in particular, to...

Read more
Nanomedicine & Bioengineering

Publications

Book – Nanoparticles in Life Sciences and Biomedicine

  Book – Nanoparticles in Life Sciences and Biomedicine The creation of new and more efficient therapies for improving human health greatly depends on drug...

Read more